PTPN6 and adult T-cell leukemia/lymphoma: Interestingly, methylation inactivation of the SHP1 promoter was more frequently seen in the acute (60%) and the lymphoma (80%) form of ATLL, which have the worst prognosis and lowest survival rate [45].